1. Home
  2. BGI vs CTXR Comparison

BGI vs CTXR Comparison

Compare BGI & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGI
  • CTXR
  • Stock Information
  • Founded
  • BGI 1879
  • CTXR 2007
  • Country
  • BGI Canada
  • CTXR United States
  • Employees
  • BGI N/A
  • CTXR N/A
  • Industry
  • BGI
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGI
  • CTXR Health Care
  • Exchange
  • BGI Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • BGI 18.0M
  • CTXR 14.6M
  • IPO Year
  • BGI 2005
  • CTXR N/A
  • Fundamental
  • Price
  • BGI $0.91
  • CTXR $1.08
  • Analyst Decision
  • BGI
  • CTXR Strong Buy
  • Analyst Count
  • BGI 0
  • CTXR 3
  • Target Price
  • BGI N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • BGI 57.4K
  • CTXR 5.9M
  • Earning Date
  • BGI 07-15-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • BGI N/A
  • CTXR N/A
  • EPS Growth
  • BGI N/A
  • CTXR N/A
  • EPS
  • BGI N/A
  • CTXR N/A
  • Revenue
  • BGI $131,596,265.00
  • CTXR N/A
  • Revenue This Year
  • BGI N/A
  • CTXR N/A
  • Revenue Next Year
  • BGI N/A
  • CTXR N/A
  • P/E Ratio
  • BGI N/A
  • CTXR N/A
  • Revenue Growth
  • BGI 4.01
  • CTXR N/A
  • 52 Week Low
  • BGI $0.76
  • CTXR $0.65
  • 52 Week High
  • BGI $2.99
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • BGI 51.08
  • CTXR 58.10
  • Support Level
  • BGI $0.86
  • CTXR $0.76
  • Resistance Level
  • BGI $0.93
  • CTXR $1.22
  • Average True Range (ATR)
  • BGI 0.07
  • CTXR 0.24
  • MACD
  • BGI 0.01
  • CTXR 0.01
  • Stochastic Oscillator
  • BGI 72.29
  • CTXR 23.53

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: